Page last updated: 2024-08-05 11:37:58

14beta-hydroxy steroid

A 14-hydroxy steroid in which the hydroxy group has a beta-configuration.

ChEBI ID: 36862

Members (12)

MemberDefinitionRole
bufalinA 14beta-hydroxy steroid that is bufan-20,22-dienolide having hydroxy substituents at the 5beta- and 14beta-positions. It has been isolated from the skin of the toad Bufo bufo.bufalin
convallatoxinA cardenolide glycoside that consists of strophanthidin having a 6-deoxy-alpha-L-mannopyranosyl (L-rhamnosyl) group attached at position 3.convallatoxin
deslanosideA cardenolide glycoside that is lanatoside C with the acetoxy group replaced by a hydroxy group.deslanoside
digitoxigeninA 5beta-cardenolide that is 5beta-cardanolide with hydroxy substituents at the 3beta- and 14beta-positions and double bond unsaturation at C(20)-C(22).digitoxigenin
digoxigeninA hydroxy steroid that consists of 5beta-cardanolide having a double bond at the 20(22)-position as well as hydroxy groups at the 3beta-, 12beta- and 14beta-positions. It has been isolated from the plant species of the genus Digitalis.digoxigenin
gitoxigeningitoxigenin
helveticosideA cardenolide glycoside that consists of strophanthidin having a digitoxosyl group attached at position 3.helveticoside
oleandrigeninA steroid ester that is the 16-acetyl derivative of gitoxigenin.oleandrigenin
oleandrinA steroid saponin that consists of oleandrigenin having a 2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl residue attached to the oxygen function at position 3.oleandrin
ouabageninA hexahydroxy steroidal lactone obtained by hydrolysis of ouabain.ouabagenin
ouabainA steroid hormone that is a multi-hydroxylated alpha-L-rhamnosyl cardenoloide. It binds to and inhibits the plasma membrane Na(+)/K(+)-ATPase (sodium pump). It has been isolated naturally from Strophanthus gratus.ouabain
strophanthidinstrophanthidin

Research

Studies (18,209)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199011,062 (60.75)18.7374
1990's3,975 (21.83)18.2507
2000's1,796 (9.86)29.6817
2010's1,160 (6.37)24.3611
2020's216 (1.19)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials93 (0.48%)5.53%
Reviews483 (2.50%)6.00%
Case Studies59 (0.31%)4.05%
Observational1 (0.01%)0.25%
Other18,657 (96.70%)84.16%